PARVIGEN, gyva liofilizuota vakcina ir skiediklis
PARVIGEN, gyva liofilizuota vakcina ir skiediklis
Authorised
- Canine parvovirus, strain Cornell 780916, Live
Product identification
Medicine name:
PARVIGEN, gyva liofilizuota vakcina ir skiediklis
Active substance:
- Canine parvovirus, strain Cornell 780916, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Canine parvovirus, strain Cornell 780916, Live10000000.00/tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC57
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- VIRBAC
Responsible authority:
- SFVS
Authorisation number:
- LT/2/92/0022/001-004
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
